Skip to main content
The Journal of Global HealthInternational Health JournalEvidence for health where it's hardest to deliver
Vol.
XXIV
No.
04
Year
2026
Menu

Quick Links

ArticlesCommunity ForumContact
Language
Appearance
Field Diagnostics · Public Health Surveillance

Point-of-Care Analyzers: A Field Procurement Guide

Global Health Equipment Review·Field Series·Evidence Desk·Peer-reviewed in spirit · Educational

Near-patient haematology, chemistry, CD4 enumeration, and viral-load platforms promise a laboratory result without a laboratory. The hard question is whether the instrument — and its cartridges — survive the journey to where the patient actually is. This guide grades analyzers on environmental tolerance, the hidden second cold chain, quality control without a lab, and honest throughput.

Read the selection criteriaField Diagnostics pillar
Plate II
Fig. — field plate
Figure. Engraved reference plate — evaluating equipment on field resilience, not lab-bench ideals.
First principles

What a point-of-care analyzer is — and what it asks of you in return

A point-of-care analyzer is a self-contained instrument that runs a quantitative assay on a small whole-blood or capillary sample at the patient interface, returning a number rather than a line. The categories that carry most of the global-health burden are haematology (haemoglobin, sometimes a partial blood count), clinical chemistry (glucose, creatinine, electrolytes, liver enzymes), CD4 enumeration for HIV staging, and HIV viral load for treatment monitoring. Each replaces a centralised laboratory step with a decentralised one — and that is the entire value proposition in a setting where the reference lab is a day's travel and a referred sample may never come back.

The trade is that the laboratory's environmental control travels with the instrument or it does not travel at all. A bench analyzer assumes a stable 20 °C room, a clean power supply, a trained technologist, and a calibration schedule. A field analyzer must earn the same result on a depleted battery, in 38 °C ambient humidity, handled by a clinician who is not a laboratorian. Whether it does is a procurement question, not a marketing one — and the datasheet's headline accuracy figure is generated under exactly the conditions you will not have.

How diagnostics feed surveillance
Plate II
Fig. — field plate
Figure. Engraved reference plate — evaluating equipment on field resilience, not lab-bench ideals.
The dependency that decides everything

The second cold chain hidden in the cartridge

The single most consequential variable in analyzer selection is not the instrument — it is its consumable. Cartridge-based platforms vary enormously in what they demand of storage. Some CD4 cartridges are stable at room temperature with a shelf life on the order of six months, which is exactly what makes them deployable to a remote post where reliable refrigeration and a clean electrical supply cannot be assumed. Others — several molecular viral-load assays in particular — carry reagents with their own refrigeration limits, effectively bolting a second cold chain onto the one already keeping vaccines viable.

That second cold chain is the quiet failure point. A logistician who has budgeted passive cool-box capacity for an immunisation campaign may discover that the diagnostics consumables compete for the same finite cold space, or worse, that a heat excursion has silently voided a tray of cartridges with no visible sign. The discipline is to read the cartridge's storage envelope before the instrument's specifications, verify it against the conditions the supply chain can actually hold, and put a dedicated temperature logger in the diagnostics consumables — not borrow a reading from the vaccine fridge three tents away.

Cold-chain monitoring
Review criteriaBy which we judge field gear
01Criterion
< 30 min
Typical result window for portable CD4 enumeration
02Criterion
~6 mo
Room-temperature shelf life of some CD4 cartridges — verify per platform
03Criterion
15–30 °C
Common labelled operating range for portable analyzers; many tolerate wider, cartridges less so
04Criterion
0
Named-product endorsements or commercial links
Standards of the desk
From the review desk

The four analyzer classes in field use

Each class answers a different clinical question and carries a different field burden. Match the instrument to the programme's actual decisions, not to the breadth of the menu.

  1. 01

    Haematology (haemoglobin)

    Portable photometric haemoglobin analyzers return a result in seconds from a single drop and are the workhorse for anaemia screening in antenatal, nutrition, and transfusion programmes. The instrument is rarely the limit — cuvette and microcuvette heat-and-humidity stability varies sharply between product generations, so qualify the consumable, not just the meter.

    RDT field guide
  2. 02

    Clinical chemistry

    Handheld and small benchtop chemistry analyzers for glucose, creatinine, electrolytes, and liver function support drug-safety monitoring and acute care where a central lab is out of reach. Multi-analyte cartridges add convenience but concentrate the cold-chain and calibration burden into a single perishable consumable.

    Field Diagnostics
  3. 03

    CD4 enumeration

    Portable CD4 platforms stage HIV disease at diagnosis from venous or capillary blood in under thirty minutes. Battery operation and room-temperature reagents on some platforms make them genuinely field-deployable; others retain a flow-cytometry heritage that demands more controlled conditions.

    HIV field testing
  4. 04

    HIV viral load

    Near-patient molecular viral-load testing monitors treatment response and detects failure where centralised testing turnaround is measured in weeks. It is the most demanding class on power, ambient control, and reagent cold chain — and the one where the second-cold-chain question matters most before committing.

    HIV field testing
ArticleField Series

What to evaluate before committing to a platform

A portable analyzer is a multi-year commitment to an entire ecosystem — instrument, cartridges, calibrators, controls, service, and the supply chain that feeds all of them. Evaluate it as a system on the criteria a field environment actually tests, in roughly this order of consequence.

Environmental tolerance

Read the operating envelope for both the instrument and its consumable, and treat them as separate numbers. An analyzer may tolerate 0–50 °C while its cartridges degrade above 30 °C; the binding constraint is always the weaker of the two. Demand a stated operating temperature and humidity range, and treat any consumable without a documented stability claim under heat and humidity as unproven for tropical deployment.

The cartridge cold chain

Establish whether reagents are room-temperature stable or refrigeration-dependent before anything else. A room-temperature platform with a six-month shelf life is a different logistical animal from one that adds a refrigerated reagent line to your campaign. This single fact reshapes the supply plan more than any performance figure.

Operator-error margin and read-out

Field results are produced by clinicians, nurses, and community health workers, not laboratorians. The questions are how many manual steps stand between sample and result, how forgiving the instrument is of pipetting and timing variation, and whether the read-out is an unambiguous number with a clear invalid-run flag. A quantitative result is only an advantage if the operator can trust the instrument to refuse a bad run rather than report a plausible-looking wrong one.

Quality control without a laboratory

Ask what internal checks the instrument runs on each sample, whether external quality-control material is available and stable in the field, and how calibration drift is detected. An analyzer that cannot be verified against a known control is a black box producing numbers of unknown reliability — and unknown reliability in a quantitative result is worse than a qualitative test that admits its limits.

Throughput and serviceability

Match realistic throughput — single-sample run time multiplied by the manual handling between runs — against expected caseload; a thirty-minute single-cartridge run is not a high-throughput screening tool. Then ask the unglamorous service questions: battery sourcing, spare-parts lead time, whether a failed instrument can be locally swapped or must be shipped to a regional hub, and what happens to the programme during the weeks it is away.

End of section
Our field-equipment review method

Running an analyzer credibly in the field

A quantitative instrument in an uncontrolled setting earns its result through routine, not through specifications. These practices are the field substitute for a laboratory quality system.

  1. 01Step

    Qualify the consumable on arrival, not just the instrument

    Record cartridge lot and expiry on intake, log the storage range, and run a known control from the new lot before any patient sample. The instrument is rarely the failure; a heat-voided cartridge tray that still looks intact is the common one.

  2. 02Step

    Dedicate a temperature logger to the diagnostics consumables

    Do not infer cartridge temperature from the vaccine cold chain. A logger living with the reagents catches the excursion that silently degrades a perishable assay, and gives you the record to quarantine a suspect lot rather than guess.

  3. 03Step

    Run controls on a schedule the routine survives

    Internal self-checks are necessary but not sufficient. Run external positive and negative or normal-range controls on each new lot, after any cold-chain alarm, and at a fixed interval that survives staff turnover. Log every control outcome in a register that travels with the kit.

  4. 04Step

    Flag and confirm the implausible result

    A number is more dangerous than a line because it looks authoritative. Build a standing rule that a result discordant with the clinical picture triggers a repeat run, a control check, and — where stakes are high — referral, rather than action on a single reading.

  5. 05Step

    Capture the output as surveillance data

    Quantitative results — CD4 trajectories, viral-load suppression rates, anaemia prevalence — are programme-level signal, not just clinical numbers. Record instrument, lot, control status, and result so that drift, lot failures, and epidemiological trends are detectable above the level of any single test.

Method of review
Plate II
Fig. — field plate
Figure. Engraved reference plate — evaluating equipment on field resilience, not lab-bench ideals.
Honest trade-offs

Where near-patient testing earns its place — and where it doesn't

The case for the point-of-care analyzer is decentralisation: a result while the patient is still in front of you, a treatment decision that does not depend on a referral sample surviving a round trip, a CD4 stage or a viral-load number captured at the only visit the patient may make. Where loss-to-follow-up is the real clinical enemy, that immediacy can outweigh a marginal loss of analytical precision against a reference instrument.

The honest counterweight is cost-per-result, the second cold chain, and the quality-assurance gap. Cartridge economics at low volume are unforgiving; a platform sized for a busy clinic idles expensively at a small post. A refrigerated reagent line can quietly outweigh the logistical saving the instrument was bought to deliver. And a quantitative result without field QA carries a false authority that a humble qualitative test does not. Near-patient analysis is a powerful tool where its specific advantage — immediacy at the point of decision — addresses the programme's actual bottleneck. Where the bottleneck is elsewhere, a strengthened referral pathway to a central laboratory is often the better investment, and saying so is part of an honest assessment.

More surveillance editorial
Correspondence

Queries to the desk

05 entries on file
Q1.When is a point-of-care analyzer the right choice over central-lab referral?

When the programme's bottleneck is access or follow-up rather than analytical precision. If a referred sample takes weeks to return a result, or the patient is unlikely to come back for it, an immediate near-patient number — a CD4 stage at diagnosis, a viral load at a single visit — can change the clinical decision in a way the reference lab cannot. Where the central lab is reachable and the patient reliably returns, referral is often cheaper and more rigorous. The deciding question is which bottleneck the instrument actually relieves.

Q2.What does 'a second cold chain' mean and why does it matter so much?

Some cartridge-based analyzers carry reagents that require refrigeration, adding a temperature-controlled supply line on top of the vaccine cold chain. That competes for the same finite passive-cool-box and refrigeration capacity, and a heat excursion can silently void perishable cartridges with no visible sign. Establishing whether a platform is room-temperature stable or refrigeration-dependent reshapes the logistics plan more than any accuracy figure — so it is the first question to settle, not the last.

Q3.How do you assure quality on a quantitative instrument without a laboratory?

By substituting routine for infrastructure: qualify each cartridge lot with a known control before patient use, run external controls on every new lot and after any cold-chain alarm, rely on the instrument's internal self-check but never on it alone, and confirm any result that is implausible against the clinical picture. Document every control outcome in a register that travels with the kit. A number from an unverified instrument is a black box; the field quality system is the discipline that keeps it honest.

Q4.Does a portable analyzer match a reference-laboratory instrument for accuracy?

Generally it trades some analytical precision for decentralisation and speed, and the trade is usually acceptable for the decisions these instruments support — staging, screening, treatment monitoring — provided field quality control is in place. The error to avoid is treating a near-patient number as interchangeable with a reference result for purposes that demand the latter. Match the instrument to the decision it informs, validate it against local reference testing where possible, and state the limits rather than assuming equivalence.

Q5.Is this guide recommending particular analyzer products?

No. International Health publishes editorial assessment frameworks, not product endorsements. This guide describes the demands a field environment places on near-patient analysers and the criteria to evaluate them against; it names no providers and carries no commercial links. The aim is to equip procurement and field staff to judge a platform against their own deployment, not to sell one.

From the editorial desk

Equipment graded for the field, not the catalog

This guide sits within our Field Diagnostics pillar alongside the rapid-test, portable-microscopy, and HIV field-testing reviews. If you are weighing a near-patient analyzer against central-lab referral for a specific deployment, our editorial team can point you to the relevant evidence and review notes.

Contact the editorial team